Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy.
Int J Mol Sci. 2022 Mar 23;23(7):3466. doi: 10.3390/ijms23073466.
Int J Mol Sci. 2022.
PMID: 35408827
Free PMC article.
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC.
Lembo RR, Manna L, Froechlich G, Sasso E, Passariello M, De Lorenzo C.
Lembo RR, et al.
Cancers (Basel). 2022 Oct 27;14(21):5289. doi: 10.3390/cancers14215289.
Cancers (Basel). 2022.
PMID: 36358708
Free PMC article.
Item in Clipboard
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies.
Manna L, Rapuano Lembo R, Yoshioka A, Nakamura K, Passariello M, De Lorenzo C.
Manna L, et al. Among authors: rapuano lembo r.
Cancers (Basel). 2023 Nov 9;15(22):5345. doi: 10.3390/cancers15225345.
Cancers (Basel). 2023.
PMID: 38001604
Free PMC article.
Item in Clipboard
Novel Combinations of Human Immunomodulatory mAbs Lacking Cardiotoxic Effects for Therapy of TNBC.
Vetrei C, Passariello M, Froechlich G, Rapuano Lembo R, Sasso E, Zambrano N, De Lorenzo C.
Vetrei C, et al. Among authors: rapuano lembo r.
Cancers (Basel). 2021 Dec 27;14(1):121. doi: 10.3390/cancers14010121.
Cancers (Basel). 2021.
PMID: 35008285
Free PMC article.
Item in Clipboard
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.
Passariello M, Esposito S, Manna L, Rapuano Lembo R, Zollo I, Sasso E, Amato F, De Lorenzo C.
Passariello M, et al. Among authors: rapuano lembo r.
Int J Mol Sci. 2023 Jun 13;24(12):10053. doi: 10.3390/ijms241210053.
Int J Mol Sci. 2023.
PMID: 37373201
Free PMC article.
Item in Clipboard
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.
Passariello M, Ferrucci V, Sasso E, Manna L, Lembo RR, Pascarella S, Fusco G, Zambrano N, Zollo M, De Lorenzo C.
Passariello M, et al. Among authors: lembo rr.
Int J Mol Sci. 2022 May 16;23(10):5556. doi: 10.3390/ijms23105556.
Int J Mol Sci. 2022.
PMID: 35628365
Free PMC article.
Item in Clipboard
Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments.
Vetrei C, Passariello M, Froechlich G, Rapuano Lembo R, Zambrano N, De Lorenzo C.
Vetrei C, et al. Among authors: rapuano lembo r.
Cancers (Basel). 2021 Jun 8;13(12):2858. doi: 10.3390/cancers13122858.
Cancers (Basel). 2021.
PMID: 34201082
Free PMC article.
Item in Clipboard
Cite
Cite